NAVIGATION
-
Services
- Lipidomics Services
- Analytical Services
- Nano-Lipid Carrier Services
- Custom Services
- AI-Driven Lipid Research Solutions
- Order
QUICK INQUIRY
Antigen Encapsulation
InquiryIn modern vaccinology and immunotherapy, the biological performance of an antigen is closely dependent on its delivery system. Unprotected antigens—including proteins, peptides, polysaccharides, and nucleic acids—are frequently limited by enzymatic degradation, rapid systemic clearance, inefficient cellular uptake, and insufficient immune stimulation.
Alfa Chemistry provides specialized antigen encapsulation services based on advanced liposomal formulations. Through customized lipid composition design and controlled encapsulation processes, antigens are incorporated into biocompatible lipid bilayers to enhance structural stability and promote efficient immune cell uptake. These tailored liposomal systems support improved antigen presentation and immune activation in vaccine and immunotherapy research.

Why Utilize Liposomes for Antigen Delivery?
Liposomes function not merely as passive carriers but as particulate delivery systems capable of enhancing antigen stability, cellular internalization, and immunological processing.
- Structural Protection: Sensitive epitopes are shielded from proteolytic and nuclease-mediated degradation, preserving conformational integrity and biological activity.
- Efficient Uptake by Antigen-Presenting Cells (APCs): Liposomal particles are readily internalized by dendritic cells and macrophages via endocytic and phagocytic pathways, facilitating antigen processing and presentation.
- Programmable Release Profiles: Formulations can be engineered to achieve controlled or sustained antigen release, supporting prolonged immune exposure and optimized immune priming.
- Co-Delivery of Immunostimulatory Components: Liposomes enable simultaneous incorporation of antigens and adjuvants, allowing coordinated immune activation.
Comprehensive Encapsulation Capabilities
Precision formulation services are available for diverse antigen classes, with emphasis on high encapsulation efficiency (EE), physicochemical stability, and preservation of biological functionality.
| Antigen Category | Technical Focus | Representative Applications |
| Protein & Subunit Antigens | Preservation of tertiary and quaternary structure; maintenance of conformational epitopes | Recombinant vaccines; toxoid research |
| Peptide Epitopes | Stabilization of short sequences; reduction of enzymatic degradation and rapid renal clearance | Precision T-cell activation; epitope mapping |
| Nucleic Acids (mRNA/DNA) | Electrostatic complexation with ionizable lipids; optimization of endosomal escape via pH-triggered membrane destabilization | Prophylactic and therapeutic nucleic acid vaccines |
| Polysaccharides | Enhancement of immunogenicity; facilitation of helper T-cell engagement when combined with carrier proteins or adjuvants | Antibacterial conjugate vaccine development |
| Multi-Antigen Systems | Stoichiometric control of multiple components within a single vesicle | Multivalent or broad-spectrum vaccine candidates |
Tailored Lipid Carrier Design
Formulations are engineered according to the physicochemical characteristics of each antigen payload.
- Cationic and Ionizable Liposomes: Designed for electrostatic complexation with nucleic acids, facilitating intracellular delivery and endosomal escape.
- PEGylated Liposomes: Provide extended systemic circulation and reduced nonspecific clearance.
- Targeted Liposomes: Surface-functionalized with ligands (e.g., mannose, antibodies, or peptides) to promote selective engagement of defined immune cell subsets.
- Stimuli-Responsive Liposomes: Formulated to release antigen payloads in response to environmental triggers such as endosomal pH changes.
Technical Workflow
The encapsulation process follows a structured and reproducible development pathway:
1. Antigen Profiling: Evaluation of molecular weight, isoelectric point (pI), solubility, and structural stability.
2. Formulation Design: Selection of lipid components (e.g., phosphatidylcholine, cholesterol, DOPE, ionizable lipids) and encapsulation methodology, including thin-film hydration or microfluidic mixing.
3. Process Optimization: Control of particle size distribution, Polydispersity Index (PDI), and Zeta potential to ensure batch-to-batch consistency and physicochemical stability.
4. Physicochemical Characterization: Dynamic Light Scattering (DLS), Cryo-TEM, and chromatographic analysis (e.g., HPLC) are employed to verify particle size, morphology, and loading efficiency.
5. Stability Evaluation: Assessment of storage stability and thermal performance under defined experimental conditions.
Research Collaboration
With expertise in lipid chemistry and nanostructured delivery systems, Alfa Chemistry's antigen encapsulation services support the progression from antigen discovery to preclinical research. Emphasis is placed on formulation reproducibility, stability, and controlled delivery performance to facilitate downstream immunological evaluation.
For consultation regarding lipid composition optimization or encapsulation strategy development for a specific antigen system, technical specialists are available for discussion.
